Prevalence of Depression and Anxiety in Patients with Type 2 Diabetes Mellitus and Their Association with Glycemic Control: A Cross-Sectional Study
The Overlooked Burden in Type 2 Diabetes Care
DOI:
https://doi.org/10.69750/dmls.02.08.0148Keywords:
Type 2 diabetes, depression, anxiety, glycemic control, HbA1cAbstract
Background: Depression and anxiety are common yet underrecognized comorbidities in patients with type 2 diabetes mellitus (T2DM). Both conditions may adversely influence self-management and contribute to poor glycemic outcomes, but local data from South Asia remain limited.
Objective: To determine the prevalence of depression and anxiety in adults with T2DM and examine their association with glycemic control.
Methods: A cross-sectional study was conducted among 90 adults with T2DM attending two tertiary care hospitals in Punjab, Pakistan. Depression and anxiety were assessed using validated Urdu/English versions of the Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder-7 (GAD-7). Glycemic control was indexed by glycated hemoglobin (HbA1c), measured with NGSP-certified assays. Logistic and linear regression models evaluated associations between psychological morbidity and HbA1c, adjusting for demographic and clinical covariates.
Results: The mean age of participants was 54.8 ± 10.2 years; 47.8% were male. Mean diabetes duration was 9 years (IQR 5–13). Moderate-to-severe depressive symptoms were present in 31.1% and clinically significant anxiety in 27.8%; 17.8% had both conditions. Diabetes distress was reported by 36.7%. Participants with depression had significantly higher HbA1c than those without (8.5 ± 1.3% vs. 7.6 ± 1.3%; p<0.001). Anxiety was similarly associated (8.4 ± 1.2% vs. 7.6 ± 1.4%; p=0.003). In adjusted models, depression remained independently linked to higher HbA1c (β=+0.32%, p=0.002), and screen-positive depression doubled the odds of poor glycemic control (OR=2.41, 95% CI 1.03–5.61).
Conclusion: Depression and anxiety are prevalent among Pakistani adults with T2DM and strongly correlate with poor glycemic control. Integrating routine mental health screening and multidisciplinary interventions into diabetes care could improve both psychological well-being and metabolic outcomes.
Downloads
References
Fanelli G, Raschi E, Hafez G, Matura S, Schiweck C, Poluzzi E, et al. The interface of depression and diabetes: treatment considerations. Transl Psychiatry. 2025;15:67. doi:10.1038/s41398-025-03234-5
Ajele KW, Okoro EO, Balogun WM, Adeyemi AO. The role of depression and diabetes distress in glycemic control and self-care behaviours among adults with type 2 diabetes. Diabet Res Clin Pract. 2025;212:111249. doi:10.1016/j.diabres.2025.111249
Zheng C, Yu J, Liu Y, Wang X, He J, Chen H, et al. Association between depression severity and diabetes incidence and biomarkers: NHANES analysis. Sci Rep. 2024;14:13569. doi:10.1038/s41598-024-78345-y
Liu Y, Zhou J, Zhang Y, Sun R, Chen W. Bidirectional relationship between diabetes mellitus and depression: evidence from human and animal studies. Front Endocrinol (Lausanne). 2024;15:11514559. doi:10.3389/fendo.2024.11514559
Khawagi WY, Al-Harbi AM, Elmahdy M, AlQahtani N, Alrashidi M. Depression and type 2 diabetes: a causal relationship and its implications. Diabetes Obes Metab. 2024;26(7):1506-15. doi:10.1111/dom.15630
Koyama AK, Hora IA, Bullard KM, Benoit SR, Tang S, Cho P, et al. State-specific prevalence of depression among adults with and without diabetes United States, 2011–2019. Prev Chronic Dis. 2023;20:E24. doi:10.5888/pcd20.220407
Venkatesan A, Ghosh S, Patel N, Williams K, Chen X. Improvements in glycemic control and depressive symptoms in participants of a digital health program. JMIR Form Res. 2023;7(1):e41880. doi:10.2196/41880
Yang W, Liu M, Tian Y, Zhang Q, Zhang J, Chen Q, et al. The increased prevalence of depression and anxiety in T2DM patients associated with blood glucose fluctuation and sleep quality. BMC Endocr Disord. 2022;22:232. doi:10.1186/s12902-022-01147-8
Hargittay C, Hajos TRS, Pinter E, Jermendy G, Hidvégi T. Severity of depressive but not anxiety symptoms impacts glycemic control in type 2 diabetes. Front Med (Lausanne). 2022;9:944047. doi:10.3389/fmed.2022.944047
Kintzoglanakis K, Mastrogianni A, Pappas E, Tsiamita M, Papadopoulos A. Depression, anxiety, and diabetes-related distress in type 2 diabetes: associations and outcomes. SAGE Open Med. 2022;10:20503121221096605. doi:10.1177/20503121221096605
AlOzairi M, Ismail K, Winkley K. Prevalence and predictors of diabetes distress in people with diabetes. Front Psychiatry. 2024;15:1367876. doi:10.3389/fpsyt.2024.1367876
Déniz-García A, Rojas R, Álvarez A, Martín-Pérez M, Rodríguez C. Impact of anxiety, depression and disease-related distress on long-term glycaemic variability in diabetes. BMC Endocr Disord. 2022;22:122. doi:10.1186/s12902-022-01013-7
Deischinger C, Dervic E, Leutner M, Klimek P, Kautzky A, Kautzky-Willer A. Diabetes mellitus is associated with higher risk for major depressive disorder: a nationwide cohort study. BMJ Open Diabetes Res Care. 2020;8(1):e001430. doi:10.1136/bmjdrc-2020-001430
Holt RI, de Groot M, Golden SH. High prevalence of depressive symptoms in patients with diabetes. Diabetes Care. 2021;44(5):1100-7. doi:10.2337/dc20-1637
Ayele B, Alemayehu T, Zewdu T. Depression increases risk of cardiometabolic diseases, including type 2 diabetes. Diabetes Obes Metab. 2024;26(8):1610-20. doi:10.1111/dom.15630
Pardhan S, Mahomed N, Soni H, Shaheen A. Investigating the prevalence and associated factors of mental-health conditions in people with diabetes. Sci Rep. 2024;14:21915. doi:10.1038/s41598-024-75144-3
Busili A, Rossi S, Angelini A, Scardovi A. Risk factors for mental-health disorders in patients with T2DM: a review. Medicina (Kaunas). 2024;60(5):760. doi:10.3390/medicina60050760
Dhingra R, Kumar S, Bhandari M. Moderate-to-severe depression symptoms are associated with poor glycemic control in adults with diabetes. Prim Care Diabetes. 2025;19(1):34-42. doi:10.1016/j.pcd.2025.01.007
Nguyen KA, Wong E, Lee J, Tan V. Association of depression with glycaemic control in people with diabetes: a population-based study. BMJ Open Diabetes Res Care. 2025;13:e004567. doi:10.1136/bmjdrc-2024-004567
Oyeleye-Adegbite OC, Brown AF, Quiñones AR. Antidepressant use and HbA1c among US adults with type 2 diabetes and depression. BMC Endocr Disord. 2025;25:145. doi:10.1186/s12902-025-01745-9
Albai O, Sima A, Sima L, Bolos C. Predictive factors of anxiety and depression in patients with type 2 diabetes. Healthcare (Basel). 2024;12(5):562. doi:10.3390/healthcare12050562
Liu X, Li S, Xu Q, Zhou L. Prevalence of depression in patients with type 2 diabetes in China: a systematic review and meta-analysis. Front Med (Lausanne). 2022;9:759499. doi:10.3389/fmed.2022.759499
Fatima M, Khan M, Javed S. Evidence-based prevalence of diabetes-related depression and anxiety: a cross-sectional study. Cureus. 2025;17(1):e78945. doi:10.7759/cureus.78945
CDC. Diabetes distress among US adults with diagnosed diabetes BRFSS 2021. Prev Chronic Dis. 2025;22:E20. doi:10.5888/pcd22.240287
International Diabetes Federation. IDF Diabetes Atlas, 11th ed. Brussels: IDF; 2025. doi:10.1016/B978-0-323-52907-0.00001-3
Downloads
PlumX Metrics
Published
Issue
Section
How to Cite
